Parkinson's disease (PD) is the second most prevalent neurogenerative disorder, with a growing global prevalence due to population aging. Despite increased awareness and significant research advancement, Parkinson’s disease treatment options include dopamine replacement therapy, symptomatic therapies that have significantly improved quality of life and Parkinson’s disease life expectancy, but no Parkinson’s disease therapies that halt or reverse disease progression, which remains a significant unmet goal in Parkinson's disease research.
But novel treatment approaches are developing as the understanding of Parkinson's disease pathophysiology grows. These include the...
